Phase II trial of idarubicin in patients with pancreatic cancer.
Mittelman
A
A
Magill
G B
GB
Raymond
V
V
Sternberg
C N
CN
Cheng
E W
EW
Sordillo
P B
PB
Young
C W
CW
D000328:Adult; D000368:Aged; D003630:Daunorubicin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D015255:Idarubicin; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology
D015255:Idarubicin; D003630:Daunorubicin